Powered by OpenAIRE graph
Found an issue? Give us feedback
addClaim

This Research product is the result of merged Research products in OpenAIRE.

You have already added 0 works in your ORCID record related to the merged Research product.

Antenatal detection of facial clefts: is the FASP target achievable?

Authors: J Budd; G Abou Elsenoun; HA Mousa; ES Draper;

Antenatal detection of facial clefts: is the FASP target achievable?

Abstract

Background In 2010 the NHS Fetal Anomaly Screening Programme issued national guidelines and standards concerning the 18+0–21+6 Fetal Anomaly Scan. Cleft Lip +/- Palate (CL+/-P) is one of eleven congenital anomalies now monitored nationally, with a target rate for antenatal diagnosis of 75%. Here we present antenatal detection rates for CL+/-P in the East Midlands and South Yorkshire Congenital Anomaly Register (EMSYCAR) between 2005-2010 and associated anomalies. Methods All cases of oro-facial clefts, with dates of delivery between 01/01/200531/12/2010 were identified by EMSYCAR. Cases were coded using the ICD10 system, distinguishing between Q35 (CP), Q36 (CL) and Q37 (CL+P). Details of antenatal detection and associated anomalies were recorded. Results There were 600 cases of oro-facial clefting reported (13.8/10,000 deliveries (95%ci, 12.7-14.9): 403 were cases of CL (n=134) or CL+P (n=269). This rate, 9.3/10,000 (95%ci, 8.4-10.2), is virtually identical to the EUROCAT surveillance system (9.36). 70% (95%ci, 65%-75%) of cases (283/403) were diagnosed antenatally. However, this figure was significantly lower for CLs (57%;95%ci,49%-66%) than forCL+P cases (76.5%;95%ci, 71%-82%). Although antenatal detection rates are improving, from 66% (95%ci, 59%-73%) in 2005-2007 to 77% (95%ci, 68-80%) in 2008-2010, this was not quite statistically significant (p=0.07). There is also wide variation in detection rates between individual trusts (range 46%-100%) 76% of CL cases were isolated: 8.2% with chromosomal and 13.4% multiple aetiology. Rates for CL+P were 71.7%, 10.8% and 15.2%, respectively. Conclusions The FASP target of 75% for CL+/-P is being achieved across EMSYCAR. Approximately one quarter of CL+/-P cases are associated with other anomalies.

Related Organizations
  • BIP!
    Impact byBIP!
    selected citations
    These citations are derived from selected sources.
    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    0
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    Average
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    Average
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    Average
Powered by OpenAIRE graph
Found an issue? Give us feedback
selected citations
These citations are derived from selected sources.
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Citations provided by BIP!
popularity
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
BIP!Popularity provided by BIP!
influence
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Influence provided by BIP!
impulse
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
BIP!Impulse provided by BIP!
0
Average
Average
Average
Upload OA version
Are you the author of this publication? Upload your Open Access version to Zenodo!
It’s fast and easy, just two clicks!